Molecular targeted therapies for indolent lymphomas: where are we?. Hematology Meeting Reports, [S. l.], v. 3, n. 3, 2009. DOI: 10.4081/hmr.v3i3.554. Disponível em: https://journals.pagepress.net/hmr/article/view/554. Acesso em: 3 jun. 2026.